Sign in
4

Changes in Ownership

Estrella Immunopharma, Inc. Filed Acc 0001213900-25-014306

Options or other derivatives

  • Chief Financial Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Xu Jiandong · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-10-30 Grant or award : show line 1 in the form Incentive Share Option +490,796 490,796 D
2024-10-30 Grant or award : show line 2 in the form Nonstatutory Share Option +509,204 509,203 D
Loading xslF345X05/ownership.xml…